Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-25-001024

Chief Business Officer sold 10,000 shares at $30.03 ($300,300)

  • Chief Business Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Derakhshan Behrad · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-05 Exercise or conversion : show line 1 in the form +10,000 $1.93 $19,300 26,837 D
2025-02-05 Sale : show line 2 in the form −10,000 $30.03 $300,300 16,837 D
Open-market sales · 10,000 sh · avg $30.03 · $300,300

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-05 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 92,929 D
Loading xslF345X05/primarydocument.xml…